XRTX (XORTX Therapeutics Inc) Net Profit

XRTX (XORTX Therapeutics) - company brandmark

Can a biopharmaceutical company with a minimal carbon footprint grow effectively? XORTX Therapeutics Inc. (XRTX) is implementing ESG standards in nephrology research to reduce toxic waste. However, geopolitical tensions and sanctions are blocking component supplies, slowing down drug registration. The company's current net profit on this chart reflects operating income dynamics, where the metric value stands at -0.00, capturing the real financial stability of the business.

XRTX (XORTX Therapeutics Inc.) Net Profit history from 07/04/2022 to 11/01/2026

Analytical breakdowns and data insights for company XORTX Therapeutics (XRTX)

- price and consensus price forecast:
Stock Quotes XORTX Corp|XRTX - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization XORTX Corp|XRTX - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share XORTX Therapeutics|XRTX - Book Capitalization|Market Capitalization to Book Value xortx.com|XRTX - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio XORTX Therapeutics Inc.|XRTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio XORTX Therapeutics Inc|XRTX - Company Total Debt|Debts to Book Capitalization XORTX Corp|XRTX - Company Long-Term Debt|Company Short-Term Indebtedness XORTX Therapeutics|Immediate Liquidity xortx.com
- net income and valuation multiples indicators:
XRTX - Net Income
Summary company analysis:XORTX Therapeutics Inc.
Core merchandise of XORTX

XORTX Therapeutics Inc. (XRTX) focuses on developing hypouricemic agents for kidney treatment while maintaining a steady pace of clinical trials. The company's net economic effect trend reflects the final financial result after deducting all expenses, where an upward trajectory confirms growing operational efficiency and asset reliability, allowing investors to assess the business's real earnings without the time lags of quarterly reporting.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|PGEN: Net Income|PHAR (Pharming Corp) - Company Profit|Nektar Therapeutics (NKTR) - Company Net Income|Company Net Income upstreambio.com (UPB)|Company Net Income Zenas Biopharma|IMNM: Final Profit|Net Income GOSS (Gossamer Corp)|Profit After Payment of Taxes KALV|Septerna Inc - Net Income|PVLA: Company Profit|SVRA: Net Income|Final Profit RIGL (Rigel Pharma)|ANAB (AnaptysBio Corp) - Net Income|ATXS: Profit After Payment of Taxes|ENGN (enGene Holdings Inc.) - Net Profit|RAPT: Final Profit|Net Profit JBIO|ACRS - Company Net Income|Company Net Income Kyverna KYTX|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|VTYX - Net Profit|Theratechnologies (THTX) - Company Net Income|Profit After Tax AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Net Profit|Company Net Income Agenus, Inc AGEN|Net Income CLYM (Climb Bio Inc)|Net Profit zurabio.com (ZURA)|aTyr Pharma - Net Income|Profit After Payment of Taxes ADAG (Adagene Inc)|Ikena Oncology, Inc. - Net Profit|Net Financial Result Shattuck Labs, Inc. STTK|EQ: Net Profit|Net Income Connect Biopharma Holdings Limited|Company Net Income Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Net Financial Result|Net Income IFRX (InflaRx N.V.)|XFOR (X4 Pharmaceuticals, Inc) - Final Profit|Net Profit ACET (Adicet Bio, Inc.)|Net Financial Result Celularity Inc (CELU)|INMB - Company Net Income|BRNS (Barinthus Biotherapeutics PLC) - Company Profit|KZR: Net Profit|Net Income SAB Biotherapeutics Inc|Net Income AKTX|Enlivex Therapeutics, Ltd. (ENLV) - Net Financial Result|Net Income QTTB (Q32 Bio Inc.)|GeoVax Labs - Company Profit|Company Net Income Edesa EDSA|Final Profit IBIO|CARM: Net Income|xtlbio.com - Profit After Payment of Taxes|BOLT (boltbio.com) - Net Income|Company Profit HCWB|Company Net Income Aptevo Therapeutics, Inc.|aimimmuno.com - Profit After Tax|Net Profit ADTX|GRI (gribio.com) - Final Profit|Net Profit HIND (Vyome Holdings)|Net Profit Revelation Biosciences Inc REVB|INDP - Company Net Income|Final Profit SCNI (BiondVax Pharmaceuticals)|calcimedica.com (CALI) - Company Net Income|Net Income Affimed N.V.|ALLK (Allakos Inc) - Net Profit|Net Profit HOOKIPA|Net Income IGMS (IGM Biosciences, Inc.)|ITOS (iTeos Pharma) - Final Profit|Net Profit OCEA (Ocean Biomedical, Inc.)|Net Financial Result tcbiopharm.com (TCBP)|THRD - Company Net Income